BTK inhibition in myeloma: Targeting the seed and the soil

Blood

Volumn 120, Issue 9, 2012, Pages 1757-1759

  Edwards, Claire M ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BORTEZOMIB; BRUTON TYROSINE KINASE; CANCER GROWTH FACTOR; IBRUTINIB; THALIDOMIDE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; B LYMPHOCYTE; BONE DISEASE; CANCER MORTALITY; CELL ADHESION; CELL CYCLE; CELL MATURATION; CELL VIABILITY; CHRONIC LYMPHATIC LEUKEMIA; CLONOGENESIS; DRUG POTENCY; DRUG SCREENING; ENZYME INHIBITION; GENE SILENCING; MULTIPLE MYELOMA; MYELOMA; MYELOMA CELL; NOTE; OSTEOCLAST; OSTEOLYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR GROWTH; TUMOR MICROENVIRONMENT;

EID: 84865778085     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2012-07-439216     Document Type: Note

References (8)

1. Tai Y-T, Chang BY, Kong S-Y, et al. Bruton tyrosine kinase inhibition is a novel therapeutic strategy targeting tumor in the bone marrow microenvironment in multiple myeloma. Blood. 2012;120(9):1877-1887.
2. Mundy GR, Raisz LG, Cooper RA, Schechter GP, Salmon S. Evidence for the secretion of an osteoclast stimulating factor in myeloma.NEngl J Med. 1974;291(20):1041-1046.
3. Edwards CM, Zhuang J, Mundy GR. The pathogenesis of the bone disease of multiple myeloma. Bone. 2008;42(6):1007-1013.
4. Ponader S, Chen SS, Buggy JJ, et al. The Bruton tyrosine kinase inhibitor PCI-32765 thwarts chronic lymphocytic leukemia cell survival and tissue homing in vitro and in vivo. Blood. 2012;119(5):1182-1189.
5. Herman SEM, Gordon AL, Hertlein E, et al. Bruton tyrosine kinase represents a promising therapeutic target for treatment of chronic lymphocytic leukemia and is effectively targeted by PCI-32765. Blood. 2011;117(23):6287- 6296.
6. Harrison C.BTK inhibitor shows positive results in B cell malignancies. Nat Rev Drug Discov. 2012;11(2):96-97.
7. Shinohara M, Koga T, Okamoto K, et al. Tyrosine kinases Btk and Tec regulate osteoclast differentiation by linkingRANKand ITAM signals. Cell. 2008;132(5):794-806.
8. Lee SH, Kim T, Jeong D, Kim N, Choi Y. The tec family tyrosine kinase Btk Regulates RANKL-induced osteoclast maturation. J Biol Chem. 2008;283(17):11526-11534.